• Topics

  • Formats

After years of challenging the pharmaceutical industry's pricing practices and advocating for broader access to medications, it's disheartening to still be labeled a 'pharma shill' simply for supporting vaccines or trying to explain the complexities of drug pricing. The reality is far more nuanced than the false choice between blindly supporting or outright rejecting the pharmaceutical industry. Public health demands a more thoughtful approach—one where we can both champion life-saving innovations and call out the systemic issues that make these treatments inaccessible to many. It's not about choosing sides; it's about pushing for a system that values both innovation and equity.

Let's be honest—if there's a way to lower drug prices without slowing down innovation, we should go for it. But is Trump's plan realistic, or is it just another case of saying what sounds good without a real way to make it happen? Let's discuss…

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?